Brought to you by:
SVS unveils proposal outlining changes to Society bylaws
Voting members of the SVS will have the opportunity to consider a bylaws referendum, with key amendments related to membership and the composition of the SVS Executive Board. The voting follows the SVS Strategic Board of Directors’ formal approval of…
REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system compared to mechanical thrombectomy for PE treatment
Data from the REAL-PE study were presented this week at TCT 2023 (23–26 October, San Francisco, USA) demonstrating that patients treated for pulmonary embolism (PE) with the Ekos endovascular system (Boston Scientific) had lower rates of adverse events, including statistically…
Thrombolex announces new insights from the RESCUE trial with the Bashir endovascular catheter
Thrombolex has announced never-before-reported major reductions in obstruction in all of the segmental pulmonary arteries (PA), based on independent core lab data analysis of 107 patients from 18 sites in the USA, with acute intermediate-risk pulmonary embolism (PE), using the…
Highlighting original work by women: Peer-review title blazes new trail in vascular surgery
The September issue of Annals of Vascular Surgery featured 37 original, peer-reviewed scientific papers whose lead authors and researchers are women vascular surgeons. Here, editor Caitlin W. Hicks, MD, discusses the mechanics of getting the publication out, coming amid recent…
Women’s champion: Freischlag marks out value of diversity and surgeons as hospital leaders
Julie A. Freischlag, MD, used her turn as honorary guest lecturer at the 2023 Midwestern Vascular Surgical Society (MVSS) annual meeting to make a pitch for vascular surgeons to step up to the plate as hospital and institutional leaders—because that…
TCT 2023: LIFE-BTK breathes life into drug-eluting resorbable scaffolds in breakthrough for below-the-knee arteries
Results of the LIFE-BTK randomized controlled trial have just been presented at TCT 2023 (Oct. 23–26) in San Francisco. The data show that, in patients with chronic limb-threatening ischemia (CLTI) due to infrapopliteal artery disease, an everolimus-eluting resorbable scaffold was…
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and death that helped sway the FDA
Data from a patient-level meta-analysis—a factor in the Food and Drug Administration’s (FDA) recent change of position on the use of paclitaxel-coated devices to treat peripheral arterial disease (PAD)—have been made public for the first time at TCT 2023 (Oct.…
Survey suggests venous work less valued than arterial interventions
The majority of more than 300 vascular surgeons who responded to a recent survey indicated that they perceive the management of venous disease to be of less value than that of arterial disease. Investigators Misaki M. Kiguchi, MD, of MedStar…
NESVS 2023: Cambria takes over as New England SVS president
Robert Cambria, MD, recently took over as president of the New England Society for Vascular Surgery (NESVS). He was passed the presidential baton by Sean Roddy, MD, during the NESVS 2023 annual meeting, held in Boston (Oct. 6–8). Cambria is…
Prepare to submit research for VAM 2024
Organizing a Vascular Annual Meeting (VAM) takes a whole lot of time and a whole lot of long-range planning. Thus, members of the SVS Postgraduate Education Committee (PGEC) have already evaluated the 90 submitted proposals (an SVS record) for educational…